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Abstract
Background: Tobacco smoke is worldwide one of the main preventable lifestyle inhalative pollutants causing
severe adverse health effects. Epidemiological studies revealed association of tobacco smoking with epigenetic
changes at single CpGs in blood. However, the biological relevance of the often only marginal methylation changes
remains unclear.
Results: Comparing genome-wide changes in CpG methylation of three recently reported epidemiological
datasets, two obtained on whole blood and one on peripheral blood mononuclear cells (PBMCs), it becomes
evident that the majority of methylation changes (86.7 and 93.3 %) in whole blood account for changes in
granulocytes. Analyzing, in more detail, seven highly significant reported smoking-induced methylation changes at
single CpGs in different blood cell types of healthy volunteers (n = 32), we confirmatively found a strong cell-type
specificity. Two CpGs in GFI1 and F2RL3 were significantly hypomethylated in granulocytes (−11.3 %, p = 0.001; −8.
7 %, p = 0.001, respectively) but not in PBMCs of smokers while two CpGs in CPOX and GPR15 were found to be
hypomethylated in PBMC (−4.3 %, p = 0.003; −4.2 %, P = 0.009, respectively) and their subtypes of GPR15
non-expressing (−3.2 %, p = 0.027; −2.5 %, p = 0.032, respectively) and smoking-evoked GPR15 expressing T cells
(−15.8 %, p < 0.001; −13.8 %, p = 0.018, respectively) but not in granulocytes. In contrast, cg05575921 within AHRR
was hypomethylated in every analyzed cell type of smokers, but with a different degree. Both, hypomethylation at
cg05575921 in granulocytes (−55.2 % methylation change in smokers, p < 0.001) and the frequency of GPR15+ T cells
(9.8–37.1 % in smokers), possessing a specific hypomethylation at cg19859270, were strongly associated with smoking
behavior at individual level and could therefore serve as valuable biomarkers indicating a disturbed homeostasis
in smokers.
In contrast to the reported long-term persistent methylation changes in adult smokers after cessation, the
hypomethylation at cg05575921 in prenatally tobacco smoke-exposed children (n = 13) from our LINA cohort was
less stable and disappeared already within 2 years after birth.
Conclusions: Studying cell type-specific methylation changes provides helpful information regarding the
biological relevance of epigenetic modifications. Here, we could show that smoking differently affects both cells
of the innate and adaptive immune systems.
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Background
Tobacco smoke is the main preventable lifestyle risk fac-
tor causing adverse health effects including the develop-
ment of chronic obstructive pulmonary disease (COPD)
and lung cancer. A better understanding of the mecha-
nisms, leading to the harm by smoking, may yield strat-
egies to manage disease risk. Genome-wide epigenetic
studies identified strong associations between tobacco
smoke exposure and changes in DNA methylation at
single sites (CpG) in whole blood or isolated peripheral
blood mononuclear cells (PBMCs) [1–12]. It was found
that methylation changes at CpGs are dynamic but re-
versible, indicating a potential mechanism of reestablish-
ment of DNA status after cessation [5, 6, 12]. Moreover,
methylation changes at single CpGs were observed to
persist after cessation [2]. In addition to smoking-related
DNA methylation changes in adult active smokers, there
is strong evidence from newborn studies that maternal
smoking during pregnancy, especially during the second
and third trimesters, can contribute to an altered DNA
methylation pattern in cord blood [13–21] which may
also persist for years after birth [22].
Altogether, population-based studies [14–21] have
consistently shown that active tobacco smoking leads to
methylation shift at CpG level in whole blood. However,
whether and how these minor methylation changes in
whole blood associated with tobacco smoking may cause
or contribute to disease pathology remains elusive.
Furthermore, none of the epidemiological studies ex-
tended their research to clarify the cellular distribution
of methylation changes over different cell types of the
whole blood.
In our previous study, we recently have shown that ac-
tive tobacco smoking may lead to an expansion of a spe-
cialized T cell type accounting for a methylation shift at
cg19859270 in composed blood samples like whole
blood or PBMCs in adults [23]. With the present study,
we pursued the goal to prove our hypothesis that the to-
bacco smoking-induced methylation changes at CpGs in
whole blood are dissimilarly distributed among different
cell types indicating different protection mechanisms
against the harm of smoking. We therefore studied the
cell-specific methylation profiles in smokers and non-
smokers for five frequently reported CpGs from earlier
epidemiological studies [4, 6, 8]. Based on the obtained
results, our additional aim was to find biomarkers suit-
able to identify homeostasis-disturbing effect by tobacco
smoking at the subject level.
Results
Distribution of smoking-induced CpG methylation
changes in leukocytes
Recent epidemiological reports, describing epigenetic
changes in whole blood of adults by active tobacco
smoking, are mainly based on DNA extraction from
whole blood, except one report exclusively focusing on
DNA from isolated PBMCs [4]. When comparing to-
bacco smoking-evoked methylation changes at CpG sites
identified in PBMC [4] with those in whole blood [6, 8],
only a minority of significant CpGs in PBMC were con-
comitantly found in whole blood (32 out of 910, see
Fig. 1a and Additional file 1). A similar result was also
observed for CpG-annotated genes (Fig. 1b). Thus, it
seems most likely that data created from whole blood, in
first instance, indicate events occurring in granulocytes,
thereby underestimating smoking-related methylation
changes in PBMCs.
To prove this hypothesis, we exemplarily explored the
cell-specific methylation profiles in adult smokers and
non-smokers (n = 32) for five frequently reported CpGs
in recent epidemiological studies (cg02657160 in CPOX,
cg09935388 in GFI1, cg05575921 in AHRR, cg03636183
in F2RL3, and cg19859270 in GPR15). Our methylation
analyses were performed in whole blood, granulocytes,
PBMC, CD3+ T cells expressing (GPR15+ T cell) or not
(GPR15− T cell) the smoking-evoked GPR15 surface
membrane protein. For all five CpGs, smoking-induced
methylation changes were mainly found in that
leukocyte population as predicted from the comparison
of the smoking-related methylation change in PBMC
versus whole blood, based on recent reported data (see
Additional file 2: Table S2). In detail, the two analyzed
CpGs in GFI1 and F2RL3 were significantly hypo-
methylated in granulocytes of smokers (−11.2 % [confi-
dence interval, −5.0 to −17.4 %], p = 0.0013; −8.7 %
[−3.9 to −13.5 %], p = 0.0013; respectively) but not in
PBMCs (Table 1). In contrast, the two CpGs in CPOX
and GPR15 were found to be smoking-induced hypomethy-
lated in PBMC (−4.3 % [−1.8 to −6.8 %], p = 0.003; −4.2 %
[−1.2 to −7.1 %], P = 0.009; respectively) and their
Fig. 1 Venn diagram illustrating intersections of tobacco
smoking-evoked methylation changes at single CpGs (a) and their
annotated genes (b) of three different reports using genomic
DNA isolated from whole blood (WB, Zeilinger et al., n = 1793;
Guida et al., n = 745) or from separated peripheral blood mononuclear
cells (PBMC, Dogan et al., n = 111) of adult probands. The origin of data
sets is indicated
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subtypes of GPR15− T cells (−3.2 % [−0.4 to −5.9 %], p =
0.027; −2.5 % [−0.3 to −4.7 %], p = 0.032; respectively)
and GPR15+ T cells (−15.8 % [−12.2 to −19.4 %], p <
0.001; −13.8 % [−3.0 to −24.7 %], p = 0.018; respect-
ively) but not in granulocytes. Cg05575921 in the
AHRR gene body was smoking-induced hypomethy-
lated both in granulocytes and PBMC but with an
about threefold greater extent in granulocytes (−55.2 %
[−48.5 to −61.9 %], p < 0.001; −15.7 % [−10.0 to −21.3 %],
p = 0.005; respectively, see Additional file 3: Figure S4 for
methylation changes at cg19859270 [GPR15], cg03636183
[F2RL3], and cg05575921 [AHRR]). Consistently, an in-
creased AHRR gene expression was found in granulocytes
as well as PBMC of smokers compared to non-smokers
(Fig. 2).
Smoking-induced CpG methylation changes in T cells
Recently, we have reported that the specific hypomethy-
lation in the gene body of GPR15 at cg19859270 is
evoked by the expansion of GPR15-expressing T cells in
smokers. While less than 10 % of peripheral CD3+ T
cells express the GPR15 protein on their surface, smok-
ing may induce an excess of this cell population up to
40 %. To examine whether further methylation changes
in PBMC also rely on the tobacco smoking specific ex-
pansion of this cell type, we analyzed smoking-related
methylation changes for two highly significant hence
top-ranked CpGs (cg13086586 in PAICS; cg02319016 in
PAK2), exclusively reported in PBMC, together with
cg05575921 (AHRR), cg02657160 (CPOX), and
cg19859270 (GPR15) which were described differentially
Table 1 Tobacco smoking-associated methylation change at single CpG in different leukocyte populations of the blood
Gene AHRR CPOX F2RL3 GFI1 GPR15 PAICS PAK2
CpG cg05575921 cg02657160 cg03636183 cg09935388 cg19859270 cg13086586 cg02319016
Leukocyte population
Whole blood (n = 10, each group)
NS (%)a 89.8 ± 5.9 85.5 ± 2.7 77.1 ± 8.6 66.6 ± 4.9 93.9 ± 1.3 12.7 ± 1.6 91.3 ± 3.7
S (%)a 68.2 ± 8.3 83.4 ± 2.0 71.8 ± 6.9 62.2 ± 3.7 92.9 ± 1.0 13.9 ± 1.9 90.0 ± 2.2
Δmeth (%)d −21.6 (−14.8; −28.4) −2.1 (0.1; −4.3) −5.3 (0.4; −10.9) −4.4 (−0.3; −8.5) −1.0 (0.1; −2.1) 1.2 (2.8; −0.4) −1.3 (1.6; −4.2)
p valueb 2.8E−04 6.0E−02 6.6E−02 3.6E−02 4.7E−02c 1.4E−01 3.5E−01
Granulocyte (n = 10, each group)
NS (%)a 85.2 ± 7.3 85.3 ± 1.4 75.4 ± 5.5 52.9 ± 5.8 96.0 ± 0.5 12.4 ± 1.3 93.0 ± 1.5
S (%)a 30.0 ± 7.0 84.6 ± 1.7 66.7 ± 4.2 41.7 ± 7.3 95.8 ± 0.6 11.8 ± 2.8 92.3 ± 2.5
Δmeth (%)d −55.2 (−48.5; −61.9) −0.7 (0.8; −2.2) −8.7 (−3.9; −13.5) −11.2 (−5.0; −17.4) −0.2 (0.3; −0.7) −0.6 (1.5; −2.7) −0.7 (1.2; −2.6)
p valueb 1.2E−12 3.3E−01 1.3E−03 1.3E−03 4.3E−01c 1.0E+00c 4.5E−01
PBMC (n = 6, each group)
NS (%)a 92.2 ± 3.3 84.3 ± 1.6 82.0 ± 3.2 86.2 ± 2.9 93.0 ± 1.1 11.3 ± 3.1 87.2 ± 3.2
S (%)a 76.5 ± 5.2 80.0 ± 2.2 84.5 ± 8.1 83.8 ± 3.2 88.8 ± 3.1 12.5 ± 3.0 86.7 ± 0.5
Δmeth (%)d −15.7 (−10.0; −21.3) −4.3 (−1.8; −6.8) 2.5 (10.4; −5.4) −2.3 (1.6; −6.2) −4.2 (−1.2; −7.1) 1.2 (5.1; −2.8) −0.5 (2.4; −3.4)
p valueb 5.0E−03c 3.0E−03 5.0E−01 2.1E−01 9.4E−03c 4.6E−01c 3.7E−01c
CD3+GPR15− T cell (n = 6, each group)
NS (%)a 93.7 ± 2.1 84.5 ± 1.4 85.5 ± 6.6 87.7 ± 3.7 95.2 ± 1.5 11.7 ± 3.3 83.0 ± 3.5
S (%)a 90.0 ± 2.2 81.3 ± 2.7 86.0 ± 6.8 88.5 ± 2.1 92.7 ± 2.0 13.2 ± 5.2 80.7 ± 4.2
Δmeth (%)d −3.7 (−0.9; −6.4) −3.2 (−0.4; −5.9) 0.5 (9.1; −8.1) 0.8 (4.7; −3.0) −2.5 (−0.3; −4.7) 1.5 (7.1; −4.1) −2.3 (2.7; −7.3)
p valueb 1.4E−02 2.7E−02 9.0E−01 6.4E−01 3.2E−02 5.6E−01 3.2E−01
CD3+GPR15+ T cell (n = 6, each group)
NS (%)a 91.3 ± 1.9 74.8 ± 3.8 83.7 ± 6.6 87.5 ± 1.4 55.2 ± 9.4 12.8 ± 3.4 78.5 ± 4.8
S (%)a 78.7 ± 5.0 59.0 ± 1.3 86.2 ± 6.8 88.7 ± 2.5 41.3 ± 7.4 17.2 ± 8.6 68.5 ± 6.4
Δmeth (%)d −12.7 (−7.8;−17.6) −15.8 (−12.2;−19.4) 2.5 (11.1;−6.1) 1.2 (3.8;−1.4) −13.8 (−3.0;−24.7) 4.3 (12.7;−4.0) −10.0 (−2.7;−17.3)
p valueb 1.8E−04 2.0E−06 5.1E−01c 3.4E−01 1.8E−02 2.2E−01c 1.2E−02




dLimit of 95 % confidence interval in parentheses
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methylated in smoker both in studies on PBMC and
whole blood. Smoking-induced methylation changes in
T cells were found for the four CpGs in AHRR, GPR15,
CPOX, and PAK2 but not for the CpG in PAICS
(Table 1). While the CpG methylation changes in AHRR,
GPR15, and CPOX were found both in GPR15− T cells
(−3.7 % [−0.9 to −6.4], p = 0.014; −2.5 % [−0.3 to −4.7],
p = 0.032; −3.2 % [−0.4 to −5.9], p = 0.027; respectively) and
GPR15+ T cells (−12.7 % [−7.8 to −17.6], p < 0.001; −13.8 %
[−3.0 to −24.7], p = 0.018; −15.8 % [−12.2 to −19.4],
p < 0.001, respectively), changes for PAK2 were only
present in GPR15+ T cells (−10.0 % [−2.7 to −17.3],
p = 0.012). However, the degree of methylation
change was dissimilarly distributed between the two
T cell types (Fig. 2). The evoked hypomethylation in
smokers was much less pronounced in GPR15− T
cells (<4 % difference in methylation) than in GPR15+ T
cells (10.0 to 15.8 % difference in methylation). Thus, be-
side cg19859270 in GPR15, the GPR15+ T cell subpopula-
tion may also account for further smoking-induced
methylation changes observed in PBMC. Interestingly, be-
side cg19859270 in GPR15 gene body, the chromosomal
adjacent CpG site cg02657160 in CPOX may serve as an
additional cell type-specific CpG site for GPR15+ T cells
since this CpG was significantly hypomethylated in
GPR15+ T cells (p < 0.001), irrespective of smoking
behavior.
Biomarkers for tobacco smoking
To find out the best biomarker describing the systemic
perturbation of homeostasis by tobacco smoking, we
compared the flow-cytometric analyzed frequency of
smoking-evoked GPR15+ T cells (CD3+) with the degree
of methylation at the most conspicuous CpG site
cg05575921 (AHRR) in granulocytes and the blood con-
centration of the nicotine metabolite cotinine at individ-
ual level. As indicated in Fig. 3, active smokers could be
identified by (i) an elevated blood cotinine level (Fig. 3a),
(ii) a frequency of GPR15+ T cells above 9 % (Fig. 3b),
or (iii) a methylation degree below 40 % at cg05575921
(AHRR) in granulocytes (Fig. 3c). Both frequency of
GPR15+ T cells and cg05575921 methylation did not
correlate as in non-smokers (Spearman rS = −0.56, p =
0.0931) as in smokers (rS = −0.42, p = 0.22, see Add-
itional file 4: Figure S3). However, the interindividual
range of the amount of GPR15+ T cell (9.8–37.1 %) is
twofold higher compared to cg05575921 methylation
level (20–39 %) in smokers. Thus, for clinical purpose,
Fig. 2 Distribution of methylation changes at single CpGs by tobacco smoking in GPR15− and GPR15+ T cells of whole blood. Highlighted are
significant methylation changes expressed in percentage. NS non-smoker, S smoker; p, P statistical significance by Student’s t test (p) or Mann-Whitney
U test (P)
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the amount of GPR15+ T cells might better reflect the
individual responses toward smoking exposure. Based
on discontinuous distribution of the amount of GPR15
+ T cell, smoking subjects may be segregated into
high-affected (>30 % GPR15+ T cells) and low-affected
(<26 % GPR15+ T cells).
Gene expression data were not considered as a bio-
marker. However, similar to the functional cg19859270,
a hypomethylated cg05575921 site in smokers is associ-
ated with an increased AHRR gene expression both in
granulocytes (2.1-fold, p = 0.017) and in PBMC (6.3-fold,
p < 0.001), thus, the cg05575921 might also belong to
functional CpG sites (Fig. 4).
Tobacco smoke-related CpG methylation pattern in early
childhood
The CpG site cg05575921 (AHRR) was reported to be
hypomethylated in cord blood of children whose mother
had sustained smoked during the two last trimesters of
pregnancy. To evaluate a putative long-lasting effect of
smoking during prenatal period, we followed the methy-
lation pattern of this CpG in children from birth on up
to the age of 4 years in whole blood. Children whose
mothers smoked during pregnancy were hypomethylated
at this CpG at birth (−6.0 % [CI, −1.4 to −10.6 %] of
methylation, P = 0.012) and at the age of 1 year (−4.1 %
[CI, −1.5 to −6.7 %], p = 0.001) but not thereafter (Fig. 5a).
Interestingly, the hypomethylation at cg05575921 at birth
disappeared in children of never-smoking mothers already
at the age of 1 year (9.1 % [CI, 6.9 to 11.3 %] increase in
methylation, p < 0.001), whereby in children of mothers
who smoked during pregnancy, a degree of hypomethy-
lation remained in spite of similar increment of methy-
lation after the first year of life (11.0 % [6.3 to 15.7 %]
increase in methylation, p = 0.011). At the individual
level, cg05575921 (AHRR) failed to discriminate new-
born with respect to the smoking exposure during preg-
nancy. At birth, only approximately 30 % (4 out of 13)
of in utero exposed newborns have shown methylation
levels below the lowest degree of methylation of 70 %
which was found in unexposed newborns. The degree of
methylation at cg05575921 in mothers did not change
between pregnancy and 1 year postpartal (Fig. 5b).
However, the degree of methylation in cord blood corre-
lated with that in maternal blood from the 34th preg-
nancy week both in tobacco smoking-non-exposed
(Spearman correlation rS = 0.46, p = 0.045) and tobaccoFig. 3 Cellular biomarkers associated with tobacco smoking. Subjects
were separated into non-smoker (white diamond), occasional smoker
(gray circle), and smoker (black circle) by both a questionnaire and
cotinine level in the blood (a). Separately, the content of GPR15+
CD3+ T cells in blood (b) and the degree of methylation at the CpG
site cg05575921 within AHRR in granulocytes (c) perfectly indicate
the systemic effect of active tobacco smoking on blood cell types
Fig. 4 Smoking-induced AHRR expression in different cell types of
the blood. The gene expression was increased in granulocytes as
well as in PBMC from tobacco smokers (n = 14) in comparison to
non-smoker (n = 10). P, Student’s t test
Bauer et al. Clinical Epigenetics  (2016) 8:83 Page 5 of 12
smoking-exposed (rS = 0.63, p = 0.020) mother-child
pairs.
Influence of cigarette smoke extract on cg05575921
(AHRR) methylation in vitro
To verify if active tobacco smoking may directly impair
the methylation at cg05575921in AHRR, we investi-
gated the response of granulocytes as well as PBMCs
isolated from adult non-smokers to aqueous cigarette
smoke extract (CSE) in vitro (n = 3) following an 48-h
exposure. However, CSE exposure did not change the
methylation at cg05575921 in AHRR (see Additional
file 5: Figure S2).
Discussion
Distribution of smoking-associated CpG among white
blood cells
One major aim of this study was to show that smoking-
related methylation changes observed in whole blood or
PBMC are rather caused by activation/expansion of spe-
cific cell types than by minor methylation changes in
each cell type.
Recently, with the smoking-evoked GPR15+ T cells,
possessing a cell type-specific hypomethylation at
cg19859270 within the gene body of GPR15, we identi-
fied such a specific cell type accounting for the minor
methylation change at cg19859270 in whole blood or
PBMC samples of smokers [23]. It has been hypothe-
sized that an up-regulation of GPR15 could explain to
some extent the health hazard of smoking with regard to
chronic inflammatory diseases [24].
Thus, we further assumed that all methylation changes
at single CpGs by tobacco smoking might be unequally
distributed among the leukocyte population of the blood.
To prove this, we chose several highly significant hence
top-ranked CpGs repeatedly highlighted in recent stud-
ies, based on isolated DNA from whole blood [6] and
PBMC [4]. As expected, we could show for the first
time, by comparing data from these two recent reports
and by our own experimental data based on separated
cell populations, that smoking-induced methylation
changes in blood are strongly cell type-specific. As
shown for cg19859270 (GPR15), even a methylation dif-
ference in blood of around 2 % by smoking may be of
strong biological relevance, if this methylation is caused
by expansion of a specific cell type, namely GPR15+ T
cells, involved in inflammation and disease pathology.
Interestingly, in all cases where the main smoking-
induced methylation change at single CpG was expected
in PBMC (cg19859270, GPR15; cg02657160, CPOX;
cg02319016, PAK2), the greatest methylation change was
found even in the GPR15+ T cells of smokers. Thus, it
can be supposed that similar to the reported cg19859270
in the GPR15 gene [23], the smoking-induced expansion
of GPR15+ T cells may be responsible for further single
methylation changes identified in whole blood or PBMC
samples in smokers.
In contrast to other CpG sites showing cell type-
specific methylation changes in smokers, the hypome-
thylation of cg05575921 within the AHRR gene was
found in different cell types. The most pronounced
methylation change emerged in granulocytes (−55.2 %
compared to non-smoker) followed by PBMC (−15.7 %)
and GPR15+ T cells (−12.7 %). Since GPR15+ T cells are
only a small subset of PBMC (about 6–28 %), it can be
assumed that monocytes additionally account for the
methylation change of about 16 % at cg05575921 in
PBMC. Smoking-induced methylation changes at
cg05575921 in antigen-presenting cell types like EBV-
immortalized lymphoblasts (corresponding to B cell) and
Fig. 5 Influence of maternal smoking during pregnancy (n = 13) on time course of methylation at cg05575921 within AHRR in the child from
birth until the age of 4 years (n = 20) (a) in comparison to the degree of smoking-related methylation changes in mothers during pregnancy and
1 year postpartal (b). Due to drop out probes, the number of tobacco smoke-exposed children during pregnancy over time is 13, 13, 11, and 8
for the ages of 0, 1, 2, and 3 years, respectively. Number of non-exposed children was always 20. *p Kruskal-Wallis ANOVA by ranks, p Student’s t test,
P Mann-Whitney U test
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alveolar macrophages may confirm this assumption [10].
The dissimilar effect size of methylation changes at
cg05575921 by tobacco smoking furthermore discounts
the previously discussed assumption of a stem cell origin
of methylation changes.
Comparing smoking-induced changes in CpG methyla-
tion of whole blood with buccal samples, it was recently
found that hypomethylated top-ranked CpGs (n = 19)
were common to both tissues [25]. This might evoke the
assumption that there are really existing CpG sites which
are affected by smoking exposure irrespective of the tissue
or cell type. However, because of (i) the absence of ex-
pected T cell-specific cg19859270 in GPR15 [26], (ii) the
presence of mainly granulocyte-specific top-ranked CpG
sites (in AHRR, F2RL3, GFI1 and others), and (iii) the
huge number of different smoking-affected CpGs s be-
tween buccal and blood samples (see Additional file 6:
Figure S1), this observation seems more likely to rely on
expected contamination of buccal samples with leuko-
cytes, especially granulocytes [27], than on a common
smoking-induced hypomethylation at identical CpG sites
both in leukocytes and buccal epithelial cells. Additionally,
because of top-ranked CpGs in aryl-hydrocarbon receptor
(AHR)-induced genes (CYP1A1, CYP1B1) in buccal sam-
ples, not conspicuous in whole blood, the concomitant
presence of hypomethylated CpGs in AHR repressor gene
(AHRR) in epithelial cells would not have been expected.
A similar conclusion could also be drawn comparing iso-
lated PBMC with whole blood. Due to contamination of
PBMC preparations with granulocytes (3 ± 2 %, according
to the manufacturer’s preparation instruction), the most
significant CpGs of whole blood were expectedly found in
PBMC (i.e., cg05575921 in AHRR, cg09935388 in GFI1,
and cg03636183 F2RL3). Vice versa, the cell type-specific
hypomethylation at cg19859270 (GPR15) of GPR15+ T
cells (approximately 2–4 % of T cells in smokers) was
found in whole blood of smokers.
Cellular biomarker for tobacco smoking effects in blood
Based on epidemiological studies, a variety of CpG sites
have been identified as potential candidates for monitor-
ing current and life-time tobacco smoke exposure,
among them several sites in F2RL3, cg05575921 in
AHRR as well as cg19859270 in GPR15. The cg05575921
in AHRR was the CpG with the highest effect size [11,
12, 20] and has additionally become of special interest,
since its methylation level was found to be changed
already after a quite short period of smoking. Philibert
and colleagues postulated that the extent of AHRR
methylation at cg0557921 in PBMC might be a potential
biomarker for the initiation of smoking because it shows
a significant hypomethylation in nascent smokers who
had an one pack-year exposure [11]. However, in that re-
port, the methylation level at one pack-year exposure
showed a broad overlapping range toward that of non-
smokers indicating the impossibility of discrimination of
subjects at the individual level by the cg0557921 methy-
lation level in PBMC.
In contrast to the reported results at a population
level, we intended to identify biomarkers suitable to
identify tobacco smoke effects at the subject level. In this
study, we have shown that the methylation level at
cg05575921 in granulocytes as well as the amount of
GPR15+ T cells may serve as highly sensitive and specific
biomarkers in blood indicating a disturbed homeostasis by
tobacco smoking at the subject level.
Comparing both biomarkers, it was evident that the
amount of GPR15+ T cells much better reflects the indi-
vidual variation in response to smoking than cg05575921
methylation level in granulocytes. It should be noted that
it was not our intension to identify a biomarker correlat-
ing with the duration or the level of tobacco smoke expos-
ure. In a century of personalized medicine, we rather
focused on specific qualitative signs for disturbed homeo-
stasis by tobacco smoking at an individual level. If GPR15
+ T cells are activated and expanded as a consequence of
lung inflammation and if the occurrence of this cell popu-
lation in peripheral blood might reflect the degree of
already established lung inflammation, it remains elusive.
However, further studies are necessary to validate whether
the amount of GPR15+ T cells may in fact indicate lung
inflammation/destruction by smoking.
Time course of methylation recovery
To exclude the possibility that the hypomethylation at
cg0557921 in AHRR might be a long-lasting effect from
mother’s smoking during pregnancy, we investigated the
time course of methylation from birth until the age of
4 years in children from smoking compared to non-
smoking mothers during pregnancy. In general, the
cg0557921 was one of the most significant CpG in cord
blood affected by tobacco smoking throughout preg-
nancy [16, 18, 20]. However, in accordance with studies
showing that DNA methylation in blood of adult
smokers after cessation approaches level of never
smokers within few years, but never completely reaches
normal levels [6, 8], we have shown that the different
methylation level at cg0557921 in cord blood of new-
borns whose mothers had smoked during pregnancy dis-
appeared until the age of 2 years. Because of the fast
recovery during the first 2 years after birth, it seems un-
likely that the hypomethylation at this CpG in adult
smokers was caused by in utero exposure. In a further
study including birth and ages of 7 and 17 years, a full
recovery of methylation at cg0557921 in whole blood to-
ward the level of those children not exposed to prenatal
maternal smoke was not reached [21]. However, in
this study, a maximum methylation was reported for
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the 7-year-old children followed by a slightly falling
down to the age of 17 years [21].
The reason for the shift in methylation at cg0557921
over time in unexposed children remains elusive. But we
think that changed methylation over the first year of life
might be a sign of physiological maturation of immune
system in general. Seemingly similar methylation
changes were also found in GFI1 and CNTNAP2 show-
ing an increase of methylation from birth to the age of
7 years [21]. Interestingly, all these three genes addition-
ally exert their function as tumor suppressor genes
(AHRR [28], GFI1 [29], CNTNAP2 [30]).
According to the time course of recovery of methyla-
tion after cessation in adults, the CpGs affected by to-
bacco smoking were classified by Guida and colleagues
as persistent (cg19859270, GPR15; cg02657160, CPOX;
cg0557921, AHRR; cg09935388, GFI1) or reversible
(cg02319016, PAK; cg13086586, PAICS) [8]. This state-
ment relied on genome-wide methylation data. However,
taken into account that smoking-induced GPR15+ T
cells are mainly central or effector memory T cells [31]
with an even longer life span, we would expect that all
conspicuous CpGs in this cell type could be interpreted
as persistent, including the cg02319016 in PAK. The
mechanistic interpretation of persistent CpGs mainly
found in granulocytes, such as cg09935388 in GFI, re-
mains unclear. In contrast to cells of the adaptive im-
mune system, innate immune cells like granulocytes are
expected to exhibit a comparable functional effector re-
sponse each time the same pathogen is encountered
[32]. Thus, activated immune cells might appear in per-
ipheral blood as long as immune cell activating tobacco
combustion products, which are deposited in the lung
during active smoking, are not eliminated.
Smoking-associated methylation changes in newborns
Comparing the most significant smoking-induced
methylation changes in cord blood [16, 17, 19] with that
of adult blood [6, 8], it is striking evident that in cord
blood exclusively those CpG-annotated genes were
highlighted which were dominantly regulated in granulo-
cytes. With decreasing significance of CpGs the AHRR,
GFI1, MYO1G, and CYP1A1 were the top leading con-
spicuous genes in cord blood with altered methylation
pattern following maternal smoking throughout preg-
nancy [16–18, 21]. According to our findings, the main
methylation changes by smoking in CpGs of AHRR and
GFI1 were attributed to granulocytes. MYO1G was iden-
tified in whole blood samples of adult smokers [6, 8] but
not in PBMC [4] indicating granulocytes as the main
source of this methylation change at this CpG. The en-
zyme of biotransformation CYP1A1 is rather expressed
in metabolic active granulocytes or monocytes than in
lymphocytes [33, 34]. Additionally, it is of special
interest that the smoking-induced hypomethylation at
cg19859270 in GPR15+ T cells, representing the adaptive
immunity, was never found in cord blood. As a potential
reason for the missing GPR15 activation in cord blood,
the presence of a specific population of suppressor T
cells protecting the fetus from an adaptive immune reac-
tion like graft-versus-host reaction in utero has been dis-
cussed [35]. Such suppressor cells were not found in
adult blood.
Missing in vitro effects of cigarette smoke extract
In a recent study, we have shown that CSE failed to in-
duce the expansion of GPR15+ T cells in vitro [23].
Thus, we hypothesized that GPR15+ T cells, rather than
being directly activated by tobacco smoke exposure, are
stimulated by antigen-presenting cells in the lung, such
as Langerhans cells, indicating a disturbed lung epithelial
homeostasis by tobacco smoking. In the current study,
we additionally have shown that CSE failed to induce hy-
pomethylation at cg05575921 in AHRR both in isolated
granulocytes and in PBMCs. This result again may give
evidence for a more complex cellular mechanism leading
to methylation changes in different cell types.
Limitations
Analyzing exclusively top-ranked CpGs in whole blood
or PBMC samples, we did not adjust for cellular com-
position. This seems to be a limitation of this study but,
first, it was proven that top-ranked CpGs are not af-
fected by composition of main blood cell types [16]. Sec-
ond, identical smoking-induced top-ranked CpGs were
repeatedly highlighted in different genome-wide associ-
ation studies (GWAS) considering [3, 6] or not consider-
ing [1, 2] cell composition of blood. Third, we have
shown that smoking-induced changes in methylation at
top-ranked CpGs were present both in cell type-
composed blood and separated blood cell types.
Altogether, this indicates the plausibility of our findings
not considering the cell composition of blood. To better
understand the mechanism or causality of impaired
methylation pattern in blood by smoking exposure, for
instance, we clearly have shown the need to discover the
cellular origin of each of the significant CpG. By this ap-
proach, we automatically would clarify if a change in
methylation at given CpG relied on cell composition of
the blood or not. On the other hand, if adjustment
would have been performed for all known cell types of
the blood, including the recently described smoking-
induced GPR15+ T cells, then methylation changes at
cg19859270 in GPR15 would not have been detected in
none of the GWAS. To overcome this limitation of in-
complete adjustment for cell composition and to
strengthen the focus on identification of biological cause
of exposure-triggered methylation changes in blood, in
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general, we advise against adjustment of datasets ob-
tained from whole blood for cell composition. An add-
itional limitation was given by missing details about
smoking behavior from blood donors; thus, we could
not interpret the excess of GPR15+ cells among T cells
to the daily frequency of smoking or cigarette pack-
years. However, from the clinical site, for therapeutic
purpose, more the individual qualitative and quantitative
endpoints are of interest and less the tobacco smoke ex-
posure leading to the phenotypic disturbance.
Conclusions
The main intention of the present study was to clarify
how to interpret the importance of epigenetic methyla-
tion changes at single CpGs in blood by tobacco smok-
ing as one candidate of harmful exposure and whether
these in general minor changes in DNA methylation in
blood could be of biological relevance. Our data provide
evidence that even minor methylation changes observed
in whole blood samples may be of strong biological rele-
vance if they can be attributed to a specific cell type. We
could found two biomarkers for a disturbed homeostasis
by tobacco smoking at subject level. Furthermore, we
could postulate that the biological adaptation toward in
utero tobacco smoke exposure is caused by cells of the
innate immunity compared to active smoking in adult-
hood where cells of the innate and additionally of the
adaptive immunity are important.
Methods
Subjects
For the present study, blood samples from three inde-
pendent human blood donation cohorts and one pro-
spective birth cohort were used. The three independent
blood donation cohorts comprised blood samples from
148 volunteers (102 non-smokers and 46 smokers) ob-
tained from the blood bank at the University of Leipzig
(Table 2). Volunteers were recruited randomly in the
years 2014/2015 (blood donation 2 cohort, n = 100) or as
case-control cohorts after questionnaire regarding their
smoking behavior (blood donation 1 [n = 25] and 3 [n = 23]
cohorts). A standardized questionnaire collected data for
age, gender, and smoking. There were no demographic
differences among non-smokers or smokers between the
three cohorts (Mann-Whitney U test, p > 0.05). Exposure
to cigarette smoke was estimated via cotinine level meas-
urement in whole blood. All volunteers were HIV-tested
negative and gave their written consent. The study was
approved by the Ethics Committee of the University of
Leipzig (079-15-09032015).
Blood samples of children and their corresponding
mothers were used from the prospective birth cohort
study LINA. Prenatal tobacco smoke-exposed children
were defined due to maternal urine cotinine levels
(>100 μg/g creatinine at the 34th week of pregnancy;
controls, <1 μg/g creatinine). The same children and
their mothers were investigated at consecutive time
periods (see Additional file 7: Table S4). Participation
in the study was voluntary, and informed consent was
obtained from all participants. The study was approved
by the Ethics Committee of the University of Leipzig
(046-2006, 160-2008).
Leukocyte separation
PBMCs were obtained by density-gradient centrifugation
using Ficoll-Paque (GE Healthcare, Solingen, Germany).
Granulocytes from fresh blood were obtained by
Table 2 Description of study subjects
A) Adult cohorts (n = 3)
Gender Cell type
Male Female
Blood donation 1 (whole blood) Granulocyte
PBMC
Subject 17 8
Agea 42 (24–66) 43 (30–65)
Tobacco smoking
No 5 6
Yes >5 cig/day 9 1
<10 cig/week 3 1
Blood donation 2 (whole blood) Whole blood
Subject 53 47




Blood donation 3 (buffy coat) PBMC GPR15±
T cells
Subject 14 9




B) Child cohort (LINA)
Whole blood Whole blood
Smoking throughout
pregnancy





PBMC peripheral blood mononuclear cells
aMedian (min-max)
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density-gradient centrifugation using Mono-Poly resolv-
ing medium (MPRM, MP Biomedical, Heidelberg,
Germany) within 2 h after donation. To enhance the
purity of granulocytes, MPRM was overlayed with
Ficoll-Paque. GPR15+CD3+ and GPR15−CD3+ T cells
were separated by flow-cytometric cell sorting after
antibody staining of PBMCs for CD3 and GPR15 sur-
face proteins as indicated below. The rationale of the
implementation of this cell type was given by our recent
finding that a tobacco smoking-induced hypomethyla-
tion at cg19859270 in blood was caused by the excess of
GPR15+ T cells harboring this cell type-specific CpG.
Thus, we were intended to prove if additional CpG
methylation shifts by smoking might rely on the excess
of this cell type. Flow-cytometric cell sorting was
performed at the laboratory of cytometry of the Core
Facility at the University of Leipzig.
Flow-cytometric analysis
All antibody incubation and wash steps were performed
in PBS/1%FCS at room temperature. First, the PBMCs
were stained for GPR15 and thereafter for the CD3 surface
receptor. Briefly, cells were incubated with anti-GPR15
antibody (1:500; R&D Systems, Wiesbaden-Nordenstadt,
Germany) supplemented with 5 % goat serum for 1 hour
and stained with R-phycoerythrin-labeled anti-mouse
IgG2b (1:500; Biozol, Eching, Germany). Free IgG2b bind-
ing sites were blocked thereafter with 5 % mouse serum
for 30 min followed by staining for leukocyte differenti-
ation receptor (anti-CD3-FITC [1:200, Beckman Coulter,
Krefeld, Germany]). The stained cells were examined for
fluorescence with the FACS Canto II and analyzed with
BD FACSDIVA software (version 8.0.1, BD Biosciences,
Heidelberg, Germany). When analyzing leukocytes in
whole blood, the first incubation step was performed dir-
ectly in 100 μl of blood samples. Erythrocytes were lysed
in FACS Lysing solution (BD Bioscience, Heidelberg,
Germany) according to the manufacturer’s instruction im-
mediately before fluorescence measurement.
Cotinine ELISA
The cotinine concentration in plasma of blood or blood
buffy coat samples was measured using the Cotinine dir-
ect ELISA Kit according to the manufacturer’s instruc-
tion (DRG Instruments GmbH, Marburg, Germany). A
cotinine level exceeding the sensitivity level of the assay
(1 ng/ml) was considered as smoker.
Pyrosequencing
Genomic DNA was extracted from leukocytes by using
the Blood DNA extraction kit according to the manufac-
turer’s protocol (Qiagen, Hilden, Germany). DNA bisul-
fite treatment was performed using the Epitect kit
(Qiagen) according to the manufacturer’s instruction.
Samples were immediately stored at −20 °C and thereafter
simultaneously analyzed by pyrosequencing. Methylation
assays were designed using the PyroMark Assay Design
Software 2.0 (www.qiagen.com). Primer sequences for
pyrosequencing are indicated (see Additional file 8:
Table S1). Methylation levels for the CpG site were
assessed using Pyromark Q24 pyrosequencer (Qiagen).
Selection criteria for single CpG were the significance of
replicated in different reports single CpGs as well as
their chromosomal location nearby a gene.
RNA expression
For semi-quantitative PCR (qPCR), total RNA of sepa-
rated leukocytes was prepared by using peqGold RNA
Pure (peqlab, Erlangen, Germany) according to the man-
ufacturer’s instructions. The cDNA synthesis was carried
out with 1 μg of RNA by using ImProm-II™ Reverse
Transcription System (Promega, Mannheim, Germany).
Intron-spanning primers were designed, and UPL probes
were selected by the Universal Probe Library Assay
Design Center (http://qpcr.probefinder.com/organism.jsp;
AHRR-for 5′- tgcttcatctgccgtgtg, -rev 5′- agctgccaagcctgt
gac, UPL 56; GUSB-for 5′- cgccctgcctatctgtattc, -rev 5′- t
ccccacagggagtgtgtag, UPL 57). The cycling program con-
sisted of 95 °C for 5 min, followed by 45 cycles of 95 °C
for 15 s and 60 °C for 1 min and 72 °C for 15 s on a
LightCycler 480 (Roche Applied Science, Mannheim,
Germany). PCR was performed with FastStart Universal
Probe Master Mix (Roche, Mannheim, Germany). All
reactions were performed in duplicates. Gene expres-
sion values were determined by using the 2−ΔΔCT
method [36] with GUSB as reference gene and normal-
ized to the lowest measured value.
In vitro exposure of leukocytes
Separated granulocytes and PBMC were immediately
cultured in 96-well round-bottom plates in RPMI 1640
medium supplemented with 10 % FCS, glutamine, and
25 mM HEPES (Life Technologies, Darmstadt, Germany)
without antibiotics. To prolong granulocytes survival in
vitro, they were additionally stimulated with 200 U/ml
IL1-β [37]. Cells were exposed to CSE in concentrations
of 1:1000, 1:100, and 1:10 for 2 days. For procedure of
preparation of aqueous CSE (see Bauer et al. 2015 [23]).
Cellular toxicity was assessed by trypan blue exclusion.
Statistical analysis
Smoking-dependent differences in methylation at single
CpG in different cell populations were tested using the
unpaired Student’s t test (in case of normal distributed
data) or Mann-Whitney U test, respectively. Test of
normality was performed using Shapiro-Wilks test.
Since we focused here only on a selected set of CpGs,
frequently reported in earlier studies as differentially
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methylated according to tobacco smoke exposure, stat-
istical correction for multiple testing was not indicated.
The non-parametric Spearman correlation was used to
describe relationship between the two highlighted bio-
markers and between methylation levels of mothers and
their children at single CpG. Multiple comparison of
cg05575921 methylation over the first 4 years of chil-
dren’s life was assessed by Kruskal-Wallis ANOVA by ranks
(p < 0.016 was considered to be significant). Age-dependent
differences in methylation at cg05575921 between tobacco
smoke-exposed and non-exposed children during preg-
nancy and their mothers were calculated by Student’s t test
or Mann-Whitney U test. Boxes in figures indicate the 25
and 75 % percentile, whiskers the non-outlier range, and
dots the outlier. All p values <0.05 were considered to be
significant. All statistical calculations were performed with
Statistica for Windows version 10 (StatSoft Inc. Europe).
Statistical values from three implemented epidemio-
logical studies are indicated as have been published by
the authors.
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